| |
| |
|
| Insider
Information: |
Winger Dennis L |
| Relationship: |
Director |
| City: |
|
| State: |
|
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
6 |
|
| Direct
Shares |
288,465 |
|
|
Indirect Shares
|
11,500 |
|
|
| Direct
Value |
$3,304,155 |
|
|
|
Indirect Value
|
$2,609,390 |
|
|
| Total
Shares |
299,965 |
|
|
| Total
Value |
$5,913,545 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Applera-Applied Biosys |
ABI |
Senior Vice President ... |
2008-11-21 |
0 |
2003-07-11 |
0 |
Premium* |
|
|
Heron Therapeutics Inc |
HRTX |
Director |
2006-08-11 |
69,544 |
2003-07-25 |
0 |
Premium* |
|
|
Vertex Pharmaceuticals Inc |
VRTX |
Director |
2012-03-09 |
6,500 |
2010-02-16 |
6,500 |
Premium* |
|
|
Accuray Inc |
ARAY |
Director |
2017-11-30 |
162,181 |
2010-11-30 |
0 |
Premium* |
|
|
Nektar Therapeutics |
NKTR |
Director |
2018-08-21 |
42,750 |
2018-08-21 |
5,000 |
Premium* |
|
|
Pacira Pharmaceuticals, Inc. |
PCRX |
Director |
2017-06-14 |
7,490 |
2014-12-05 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
208 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 9
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| HRTX |
Heron Therapeutics Inc |
Director |
– • – |
2003-07-25 |
4 |
A |
$1.67 |
$4,501 |
D/D |
2,695 |
34,412 |
|
- |
|
| HRTX |
Heron Therapeutics Inc |
Director |
– • – |
2003-11-19 |
4 |
A |
$2.23 |
$3,501 |
D/D |
1,570 |
35,982 |
|
- |
|
| HRTX |
Heron Therapeutics Inc |
Director |
– • – |
2004-05-12 |
4 |
A |
$2.45 |
$9,499 |
D/D |
3,392 |
39,374 |
|
- |
|
| HRTX |
Heron Therapeutics Inc |
Director |
– • – |
2004-09-02 |
4 |
A |
$3.35 |
$5,002 |
D/D |
1,493 |
40,867 |
|
- |
|
| HRTX |
Heron Therapeutics Inc |
Director |
– • – |
2004-11-17 |
4 |
A |
$1.35 |
$5,500 |
D/D |
4,074 |
44,941 |
|
- |
|
| HRTX |
Heron Therapeutics Inc |
Director |
– • – |
2005-03-15 |
4 |
A |
$1.65 |
$5,000 |
D/D |
3,030 |
47,971 |
|
- |
|
| HRTX |
Heron Therapeutics Inc |
Director |
– • – |
2005-05-12 |
4 |
A |
$1.44 |
$5,499 |
D/D |
3,819 |
51,790 |
|
- |
|
| HRTX |
Heron Therapeutics Inc |
Director |
– • – |
2005-08-11 |
4 |
A |
$1.66 |
$3,984 |
D/D |
2,400 |
54,190 |
|
- |
|
| HRTX |
Heron Therapeutics Inc |
Director |
– • – |
2005-11-07 |
4 |
A |
$1.74 |
$4,500 |
D/D |
2,586 |
56,776 |
|
- |
|
| HRTX |
Heron Therapeutics Inc |
Director |
– • – |
2006-03-20 |
4 |
A |
$1.53 |
$5,000 |
D/D |
3,268 |
60,044 |
|
- |
|
| HRTX |
Heron Therapeutics Inc |
Director |
– • – |
2006-05-15 |
4 |
A |
$2.00 |
$5,000 |
D/D |
2,500 |
62,544 |
|
- |
|
| HRTX |
Heron Therapeutics Inc |
Director |
– • – |
2006-05-31 |
4 |
A |
$0.01 |
$50 |
D/D |
5,000 |
67,544 |
|
- |
|
| HRTX |
Heron Therapeutics Inc |
Director |
– • – |
2006-08-11 |
4 |
A |
$1.75 |
$3,500 |
D/D |
2,000 |
69,544 |
|
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
Director |
– • – |
2010-02-16 |
4 |
B |
$38.54 |
$250,510 |
I/I |
6,500 |
6,500 |
2.1 |
- |
|
| ARAY |
Accuray Inc |
Director |
– • – |
2010-11-30 |
4 |
A |
$0.00 |
$0 |
D/D |
20,067 |
20,067 |
0 |
- |
|
| NKTR |
Nektar Therapeutics |
Director |
– • – |
2011-03-08 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,750 |
3,750 |
0 |
- |
|
| ARAY |
Accuray Inc |
Director |
– • – |
2011-11-30 |
4 |
A |
$0.00 |
$0 |
D/D |
29,925 |
49,992 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
Director |
– • – |
2012-03-09 |
4 |
D |
$41.65 |
$1,613,938 |
D/D |
(38,750) |
6,500 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
Director |
– • – |
2012-03-09 |
4 |
A |
$34.05 |
$1,323,238 |
D/D |
38,750 |
45,250 |
0 |
- |
|
| NKTR |
Nektar Therapeutics |
Director |
– • – |
2012-09-14 |
4 |
B |
$9.18 |
$45,908 |
I/I |
5,000 |
5,000 |
2.1 |
- |
|
| ARAY |
Accuray Inc |
Director |
– • – |
2012-11-30 |
4 |
A |
$0.00 |
$0 |
D/D |
19,108 |
69,100 |
0 |
- |
|
| NKTR |
Nektar Therapeutics |
Director |
– • – |
2012-12-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,500 |
11,250 |
0 |
- |
|
| ARAY |
Accuray Inc |
Director |
– • – |
2013-03-05 |
4 |
B |
$4.30 |
$85,938 |
D/D |
20,000 |
89,100 |
2.39 |
- |
|
| ARAY |
Accuray Inc |
Director |
– • – |
2013-11-29 |
4 |
A |
$0.00 |
$0 |
D/D |
15,037 |
104,137 |
0 |
- |
|
| ARAY |
Accuray Inc |
Director |
– • – |
2014-11-28 |
4 |
A |
$0.00 |
$0 |
D/D |
17,416 |
121,553 |
0 |
- |
|
208 Records found
|
|
Page 1 of 9 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
